Phathom Pharmaceuticals (PHAT) Q2 2024 Earnings

9MayConfirmed
Q2 2023
Q3 2023
Q4 2023
Q2 2024
-1.42
-1.2
-0.98
-0.76

Details

Expected EPS
-1.32058
Actual EPS
-1.42
Surprise EPS
-0.1
Surprise Percent
+7.53%

Description

Phathom Pharmaceuticals (PHAT) has reported earnings of -1.42 per share for Q2 2024.

0 Comments

Share your thoughts